Other
Sean M. Healey & AMG Center for ALS
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed trials have results
Key Signals
2 with results
Enrollment Performance
Analytics
N/A
1(33.3%)
Phase 1
1(33.3%)
Phase 2
1(33.3%)
3Total
N/A(1)
Phase 1(1)
Phase 2(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT06165172Not ApplicableCompleted
Early Feasibility Study of the MyoRegulator® for Treatment of ALS
Role: collaborator
NCT03168711Phase 2Completed
Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)
Role: collaborator
NCT02288091Phase 1Completed
A Pilot Study of Inosine in Amyotrophic Lateral Sclerosis (ALS)
Role: collaborator
All 3 trials loaded